Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Tables)

WARRANTS (Tables)

3 Months Ended

Mar. 31, 2022

SCHEDULE OF WARRANTS OUTSTANDING AND WARRANTS ACTIVITY

Warrants outstanding and warrant activity for the three-months ended March 31, 2022 are as follows:

Description		Classification		Exercise Price				Expiration Date		Warrants Issued				Balance December 31, 2021				Warrants Cancelled/ Expired				Balance March 31, 2022

Private Placement Warrants, issued January 25, 2017		Equity		$	46.90			June 2022			85,500				85,500				-				85,500
RedPath Warrants, issued March 22, 2017		Equity		$	46.90			September 2022			10,000				10,000				-				10,000
Underwriters Warrants, issued June 21, 2017		Liability		$	13.20			December 2022			57,500				53,500				-				53,500
Base & Overallotment Warrants, issued June 21, 2017		Equity		$	12.50			June 2022			1,437,500				870,214				-				870,214
Warrants issued October 12, 2017		Equity		$	18.00			April 2022			320,000				320,000				-				320,000
Underwriters Warrants, issued January 25, 2019		Equity		$	9.40			January 2022			65,434				65,434				(65,434	)			-

											1,975,934				1,404,648				(65,434	)			1,339,214